Q: What is Soliqua used for?

Soliqua is used to treat type 2 diabetes mellitus .

Q: How does Soliqua work?

Dual Action for Blood Sugar Control Soliqua contains two active ingredients: insulin glargine and lixisenatide. Each component works in a different way to manage blood glucose levels throughout the day and after meals. Insulin Glargine Insulin glargine is a long-acting (basal) insulin. It mimics the insulin naturally produced by the body and works by: Helping cells in the body absorb sugar from the bloodstream to use for energy. Reducing the amount of sugar the liver produces and releases into the blood. This component provides a steady level of insulin for about 24 hours, helping to keep blood sugar stable between meals and overnight. Lixisenatide Lixisenatide belongs to a class of drugs called GLP-1 receptor agonists. It mimics a natural hormone in the body to help lower blood sugar, particularly after eating. It works by: Signaling the pancreas to release more insulin when blood sugar levels are high. Decreasing the release of glucagon, a hormone that tells the liver to make more sugar. Slowing down the speed at which the stomach empties, which helps prevent blood sugar spikes after meals. By combining these two medications, Soliqua addresses blood sugar management through multiple pathways in the body.

Q: What are the active ingredients in Soliqua?

The active ingredients in Soliqua are lixisenatide and insulin glargine .

Q: What are the side effects of Soliqua?

Common side effects of Soliqua may include: Hypoglycemia Nausea Diarrhea and others. Always consult with a healthcare professional about potential side effects.

Q: Is Soliqua safe during pregnancy and breastfeeding?

Pregnancy There is limited research regarding the use of Soliqua in pregnant women. Animal studies on lixisenatide, one of the active ingredients in Soliqua, have shown potential risks to the developing fetus. However, it is important to note that poorly controlled diabetes during pregnancy can lead to serious complications for both the mother and the baby, including birth defects, high blood pressure, and pregnancy loss. Because the risks are not fully understood, healthcare providers often recommend using insulin alone to manage blood sugar levels during pregnancy. If you are pregnant or planning to become pregnant, you should discuss the benefits and risks of your treatment options with your doctor. Breastfeeding It is currently unknown if Soliqua passes into human breast milk or how it might affect a nursing infant. Many medications can be excreted in breast milk and may cause side effects in a baby. Because of the potential for adverse reactions, a decision must be made whether to stop breastfeeding or stop using the medication. If you are breastfeeding or planning to breastfeed, consult your healthcare professional to determine the safest course of action for you and your child.

Q: What forms and strengths does Soliqua come in?

Available Forms Soliqua is provided as a clear, colorless solution for injection. It is available in the following form: Pre-filled disposable pen: A single-patient-use pen used to deliver the medication subcutaneously. This medication is a combination product containing a long-acting human insulin analog and a glucagon-like peptide-1 receptor agonist. It is designed to be used with disposable needles.

Q: What is the FDA approval status of Soliqua?

FDA Approval and Indications Soliqua 100/33 is approved by the U.S. Food and Drug Administration (FDA) for use in adults with type 2 diabetes. It is a combination of two medications: insulin glargine, a long-acting insulin, and lixisenatide, a GLP-1 receptor agonist. It is intended to be used alongside diet and exercise to manage blood glucose levels. Safety Communications and Monitoring The FDA has monitored several safety signals related to Soliqua through its adverse event reporting systems: Medication Errors: The FDA identified potential risks regarding medication errors, such as receiving the wrong dose or the wrong drug, in early 2018. Anaphylactic Reactions: In 2020, the FDA evaluated reports of serious allergic reactions, including anaphylaxis, associated with the medication. Suicidal Ideation: The FDA has conducted evaluations regarding reports of suicidal thoughts or actions in patients taking GLP-1 receptor agonists. As of early 2024, the FDA's preliminary review has not found evidence that these medications cause such thoughts or actions, but the agency continues to study the issue. There are no boxed warnings currently listed for Soliqua in the provided regulatory documentation.

Question 1

What is Soliqua?

Accepted Answer

Soliqua is a combination of two different medications used to help control blood sugar. It contains insulin glargine, a long-acting insulin, and lixisenatide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist.

These two components work through different mechanisms to help the body regulate glucose levels. By using both a long-acting insulin and a GLP-1 receptor agonist, the medication helps maintain more stable blood sugar levels.

Question 2

What is Soliqua used for?

Accepted Answer

Soliqua is used to treat type 2 diabetes mellitus.

Question 3

How does Soliqua work?

Accepted Answer

Dual Action for Blood Sugar Control

Soliqua contains two active ingredients: insulin glargine and lixisenatide. Each component works in a different way to manage blood glucose levels throughout the day and after meals.

Insulin Glargine

Insulin glargine is a long-acting (basal) insulin. It mimics the insulin naturally produced by the body and works by:

Helping cells in the body absorb sugar from the bloodstream to use for energy.
Reducing the amount of sugar the liver produces and releases into the blood.

This component provides a steady level of insulin for about 24 hours, helping to keep blood sugar stable between meals and overnight.

Lixisenatide

Lixisenatide belongs to a class of drugs called GLP-1 receptor agonists. It mimics a natural hormone in the body to help lower blood sugar, particularly after eating. It works by:

Signaling the pancreas to release more insulin when blood sugar levels are high.
Decreasing the release of glucagon, a hormone that tells the liver to make more sugar.
Slowing down the speed at which the stomach empties, which helps prevent blood sugar spikes after meals.

By combining these two medications, Soliqua addresses blood sugar management through multiple pathways in the body.

Question 4

What are the active ingredients in Soliqua?

Accepted Answer

The active ingredients in Soliqua are lixisenatide and insulin glargine.

Question 5

What are the side effects of Soliqua?

Accepted Answer

Common side effects of Soliqua may include:

Hypoglycemia
Nausea
Diarrhea
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Soliqua?

Accepted Answer

Soliqua belongs to the combination basal insulin and GLP-1 receptor agonist drug class.

Question 7

What is the dosage of Soliqua and how do I take it?

Accepted Answer

Soliqua is injected under the skin once every day. It is important to use the medication within one hour before your first meal of the day. Your healthcare provider will show you how to prepare and inject the medication properly.

Injection Sites

You can inject Soliqua into the abdomen, thigh, or upper arm. It is important to rotate the injection site with each dose to help prevent skin problems like lumps or pits at the injection site.

Administration Tips

Always use a new needle for each injection to prevent infection and needle blockage.
Check the liquid in the pen before use; it should be clear and colorless. Do not use it if it looks cloudy, colored, or has particles.
Never share your injection pen with another person, even if the needle has been changed.
Do not mix Soliqua with any other insulin or injectable medication in the same syringe.

Missed Dose

If you miss a dose, take it within one hour before your next meal. If you do not realize you missed the dose until the next day, skip the missed dose and resume your regular schedule. Do not take two doses at once or on the same day.

Question 8

Is Soliqua safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There is limited research regarding the use of Soliqua in pregnant women. Animal studies on lixisenatide, one of the active ingredients in Soliqua, have shown potential risks to the developing fetus. However, it is important to note that poorly controlled diabetes during pregnancy can lead to serious complications for both the mother and the baby, including birth defects, high blood pressure, and pregnancy loss.

Because the risks are not fully understood, healthcare providers often recommend using insulin alone to manage blood sugar levels during pregnancy. If you are pregnant or planning to become pregnant, you should discuss the benefits and risks of your treatment options with your doctor.

Breastfeeding

It is currently unknown if Soliqua passes into human breast milk or how it might affect a nursing infant. Many medications can be excreted in breast milk and may cause side effects in a baby. Because of the potential for adverse reactions, a decision must be made whether to stop breastfeeding or stop using the medication.

If you are breastfeeding or planning to breastfeed, consult your healthcare professional to determine the safest course of action for you and your child.

Question 9

What forms and strengths does Soliqua come in?

Accepted Answer

Available Forms

Soliqua is provided as a clear, colorless solution for injection. It is available in the following form:

Pre-filled disposable pen: A single-patient-use pen used to deliver the medication subcutaneously.

This medication is a combination product containing a long-acting human insulin analog and a glucagon-like peptide-1 receptor agonist. It is designed to be used with disposable needles.

Question 10

What is the FDA approval status of Soliqua?

Accepted Answer

FDA Approval and Indications

Soliqua 100/33 is approved by the U.S. Food and Drug Administration (FDA) for use in adults with type 2 diabetes. It is a combination of two medications: insulin glargine, a long-acting insulin, and lixisenatide, a GLP-1 receptor agonist. It is intended to be used alongside diet and exercise to manage blood glucose levels.

Safety Communications and Monitoring

The FDA has monitored several safety signals related to Soliqua through its adverse event reporting systems:

Medication Errors: The FDA identified potential risks regarding medication errors, such as receiving the wrong dose or the wrong drug, in early 2018.
Anaphylactic Reactions: In 2020, the FDA evaluated reports of serious allergic reactions, including anaphylaxis, associated with the medication.
Suicidal Ideation: The FDA has conducted evaluations regarding reports of suicidal thoughts or actions in patients taking GLP-1 receptor agonists. As of early 2024, the FDA's preliminary review has not found evidence that these medications cause such thoughts or actions, but the agency continues to study the issue.

There are no boxed warnings currently listed for Soliqua in the provided regulatory documentation.

Question 11

What should I know about Soliqua and cost?

Accepted Answer

Factors Influencing Cost

The amount you pay for Soliqua is determined by several variables:

Insurance Plan: Your specific health insurance provider and plan formulary will dictate your copay or coinsurance. Some plans may require prior authorization from a healthcare provider before they agree to cover the medication.
Pharmacy Selection: Prices may differ between local retail pharmacies, large chains, and mail-order pharmacy services.
Medicare and Medicaid: Coverage for Soliqua under government programs like Medicare Part D or Medicaid varies by state and individual plan details.

Generic Availability

Soliqua is a brand-name medication containing insulin glargine and lixisenatide. Currently, there is no generic version available. Brand-name drugs typically cost more than generic alternatives because they are protected by patents that prevent other companies from making the same medication for a set period.

Financial Assistance Programs

There are several options that may help reduce the out-of-pocket cost of Soliqua:

Manufacturer Savings Cards: The drug manufacturer may offer copay cards for patients with commercial insurance. These cards can lower the monthly cost for eligible individuals.
Patient Assistance Programs: Programs such as Sanofi Patient Connection may provide the medication at a reduced cost or for free to patients who meet specific income requirements or who do not have insurance coverage.
Extra Help: Low-income individuals with Medicare may qualify for the Extra Help program, which assists with the costs of prescription drug premiums and copays.

Soliqua

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Soliqua

Hospitals.net Disclosure